Table 3 Tube replacements due to obstruction or deterioration by MDE status.
Non-MDE group | MDE group | Characteristics of MDE | |||||
|---|---|---|---|---|---|---|---|
1 MDE | > 1 MDE | Omeprazole | Aspirin | Other drugs with MDE | |||
Patients, n | 110 | 159 | 115 | 44 | 35 | 83 | 81 |
Recurrence of TRO, patients, n (%) | |||||||
Non-TRO | 83 (75.4) | 101 (63.5) | 72 (62.6) | 29 (65.9) | 17 (48.6) | 60 (72.3) | 52 (64.2) |
1 TRO | 21 (19.1) | 40 (25.2) | 30 (26.1) | 10 (22.7) | 13 (37.1) | 12 (14.5) | 22 (27.2) |
2 TRO | 6 (5.5) | 9 (5.7) | 7 (6.1) | 2 (4.5) | 1 (2.9) | 6 (7.2) | 4 (4.9) |
3 TRO | 0 (0) | 8 (5) | 5 (4.3) | 3 (6.8) | 4 (11.4) | 5 (6) | 2 (2.5) |
4 TRO | 0 (0) | 1 (0.6) | 1 (0.9) | 0 (0) | 0 (0) | 0 (0) | 1 (1.2) |
TRO per patient, mean (SD) | 0.30 (0.57) | 0.54 (0.86) | 0.55 (0.86) | 0.52 (0.87) | 0.77 (0.97) | 0.47 (0.87) | 0.49 (0.81) |